The Canadian Arthritis Patient Alliance is pleased to be presenting two posters at the EULAR 2026 Congress (European Congress of Rheumatology) taking place June 3–6 in London, UK. CAPA’s Managing Director, Laurie Proulx, is attending the conference and presenting two...
CAPA’s Managing Director Laurie Proulx presented at the Canadian Society for Immunology annual meeting (April 26-26, 2026) in the community-based discussion section of the event. View Presentation...
CAPA’s Managing Director Laurie Proulx presented in a panel discussion at Canada’s Drug Agency (CDA) 2026 Symposium on April 22, 2026. The session’s topic was Integrating Patient Perspectives and Evolving Patient Input in HTA and Laurie’s...
CAPA Board members Jenny Lorca and Therese Lane participated in and presented a poster at the 46th Annual Scientific Meeting of the Canadian Pain Society on May 2, 2026. Their poster presentation, Meaningful Patient Partner Engagement in Research, highlighted the...
The Canadian Arthritis Patient Alliance is pleased to be presenting two posters at the 2026 Canadian Rheumatology Association Annual Scientific Meeting, taking place April 16–19 in Halifax. CAPA’s President, Linda Wilhelm, will be attending the conference and...
CAPA Board member Lucy Kovalova-Woods and Patient Partner in Research Linda Hunter, MScN, PhD (C), presented a poster titled “A Practical Framework for Meaningful Patient Partner Engagement in Clinical Trials” at the Clinical Trials Symposium on February 17, 2026. The...
English 
Français du Canada